Recombinant Human Anti-IL13 x Human Anti-IL4 Bispecific Antibody (scFv-IgG) (BSSG-H338)

Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-IL13 antibody variable domain are respectively connected to the N terminus of the anti-IL4 IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.

Datasheet INQUIRY

Specifications

Targets

IL13 & IL4

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Idiopathic pulmonary fibrosis

Targets

Target 1

IL13

Gene ID

3596

UniProt ID

P35225

Alternative Names

IL13; interleukin 13; P600; IL-13; interleukin-13

Target 2

IL4

Gene ID

3565

UniProt ID

D4HNR6

Alternative Names

IL4; interleukin 4; BSF1; IL-4; BCGF1; BSF-1; BCGF-1; interleukin-4; binetrakin; pitrakinra; B cell growth factor 1; interleukin 4 variant 2; B_cell stimulatory factor 1; lymphocyte stimulatory factor 1

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-IL13 x Human Anti-IL4 Bispecific Antibody (scFv-IgG) (BSSG-H338). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-IL13 x Human Anti-IL4 Bispecific Antibody (scFv-IgG) (CAT#: BSSG-H338)

Specifications

Targets

Customer Reviews and Q&As